Cargando…
Unilateral recurrent central serous chorioretinopathy (CSCR) following COVID-19 vaccination- A multimodal imaging study()
Corona virus disease-19 (COVID-19) vaccines have been approved for emergency use. Ocular adverse effects following the vaccines have been reported. PURPOSE: To report an unique case of recurrent central serous chorioretinopathy following both doses of COVID-19 vaccine. OBSERVATIONS: A 40-year-old ma...
Autores principales: | Sanjay, Srinivasan, Acharya, Isha, Kawali, Ankush, Shetty, Rohit, Mahendradas, Padmamalini |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258414/ https://www.ncbi.nlm.nih.gov/pubmed/35818570 http://dx.doi.org/10.1016/j.ajoc.2022.101644 |
Ejemplares similares
-
“Old wine in a new bottle” - post COVID-19 infection, central serous chorioretinopathy and the steroids
por: Sanjay, Srinivasan, et al.
Publicado: (2021) -
COVID-19 vaccination, dengue hepatitis, and recurrent unilateral anterior uveitis
por: Sanjay, Srinivasan, et al.
Publicado: (2023) -
Lockdown effects on a patient receiving immunosuppression for unilateral HLA- B27 associated uveitis during COVID-19 pandemic
por: Sanjay, Srinivasan, et al.
Publicado: (2021) -
Ocular steroidome in human eyes and in eyes with complex central serous chorioretinopathy (CSCR)
por: Zola, Marta, et al.
Publicado: (2023) -
COVID-19 vaccination and recurrent anterior uveitis
por: Sanjay, Srinivasan, et al.
Publicado: (2022)